Radnostix, Inc. INIS

Company Overview

Radnostix, Inc. (INIS) is associated in public market records with the OTC-traded healthcare and nuclear medicine business historically identified as International Isotopes Inc. The company operates in the nuclear medicine, radiopharmaceutical, and specialty isotope industries, with activities tied to diagnostic imaging support, isotope processing, and radiation-related healthcare products. Public disclosures indicate that its revenue base has historically come from nuclear medicine calibration standards, radiochemical products, cobalt-based services, and related processing activities used by hospitals, laboratories, and healthcare providers.

The company’s operating focus has evolved from broader isotope manufacturing and processing into healthcare-oriented nuclear medicine and theranostic applications. Public filings and investor materials indicate that the business has sought to position itself within specialized medical isotope markets that benefit from regulatory expertise, handling infrastructure, and long-standing industry relationships. Data regarding the exact timing and structure of the transition to the Radnostix branding is inconclusive based on available public sources.